HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Samuel A Wickline Selected Research

fumagillin

11/2012Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles.
9/2010Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis.
9/2009Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice.
9/2008Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.
8/2008Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits.
9/2006Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Samuel A Wickline Research Topics

Disease

18Neoplasms (Cancer)
08/2015 - 09/2003
10Atherosclerosis
01/2015 - 11/2003
9Thrombosis (Thrombus)
11/2013 - 08/2003
7Atherosclerotic Plaque (Atheroma)
01/2015 - 12/2004
7Inflammation
07/2014 - 01/2008
5Arthritis (Polyarthritis)
06/2015 - 09/2009
4Melanoma (Melanoma, Malignant)
03/2014 - 03/2005
4Pathologic Constriction (Stenosis)
01/2012 - 12/2004
4Stroke (Strokes)
09/2011 - 08/2003
3Ischemia
04/2015 - 01/2004
3Cardiovascular Diseases (Cardiovascular Disease)
01/2015 - 01/2007
3Rupture
02/2012 - 12/2004
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
05/2014 - 09/2012
2Breast Neoplasms (Breast Cancer)
01/2013 - 08/2010
2Coronary Artery Disease (Coronary Atherosclerosis)
12/2012 - 11/2012
2Body Weight (Weight, Body)
11/2012 - 08/2010
2Fibrosis (Cirrhosis)
09/2012 - 03/2009
2Nephrogenic Fibrosing Dermopathy
03/2011 - 07/2008
2Vascular System Injuries
05/2008 - 03/2004
1Neoplasm Metastasis (Metastasis)
08/2015
1Edema
01/2015
1Experimental Arthritis
10/2014
1Muscular Dystrophies (Muscular Dystrophy)
05/2014
1Carotid Artery Injuries
11/2013
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
10/2013
1Hyperoxia
07/2013
1Infection
01/2013
1Rheumatoid Arthritis
11/2012
1Cardiomyopathies (Cardiomyopathy)
09/2012
1Retinitis Pigmentosa (Pigmentary Retinopathy)
06/2011
1Kidney Diseases (Kidney Disease)
03/2011
1Vascular Diseases (Vascular Disease)
12/2009
1Myocardial Infarction
06/2009
1Cardiomegaly (Heart Hypertrophy)
03/2009
1Hypertrophy
03/2009

Drug/Important Bio-Agent (IBA)

12Contrast MediaIBA
01/2015 - 02/2006
12FibrinIBA
04/2012 - 08/2003
6fumagillinIBA
11/2012 - 09/2006
4Melitten (Melittin)IBA
10/2013 - 09/2009
4GadoliniumIBA
03/2011 - 02/2005
3perflubron (L 1913)FDA Link
08/2015 - 06/2006
3ferric oxide (iron oxide)IBA
03/2014 - 02/2005
3LigandsIBA
11/2013 - 08/2008
3Apolipoproteins E (ApoE)IBA
11/2013 - 09/2009
3Biological Markers (Surrogate Marker)IBA
11/2010 - 09/2003
3CholesterolIBA
12/2008 - 11/2003
2Small Interfering RNA (siRNA)IBA
06/2015 - 10/2014
2phenylalanyl- prolyl- arginine- chloromethyl ketone (PPACK)IBA
04/2015 - 11/2013
2FluorineIBA
01/2015 - 01/2008
2Sirolimus (Rapamycin)FDA Link
05/2014 - 05/2008
2Lipase (Acid Lipase)FDA Link
01/2014 - 11/2012
2Liposomes (Liposome)IBA
11/2013 - 02/2005
2PeptidesIBA
10/2013 - 09/2009
2gadolinium diethylene-triamine-pentaacetic acid-bis-oleateIBA
08/2013 - 08/2003
2DystrophinIBA
09/2012 - 08/2007
2RhodaminesIBA
06/2011 - 03/2011
2glucuronyl glucosamine glycan sulfate (Vessel)IBA
05/2008 - 12/2004
2Thromboplastin (Tissue Factor)IBA
02/2006 - 03/2004
1Peptide Hydrolases (Proteases)IBA
08/2015
1Matrix MetalloproteinasesIBA
08/2015
1CreatinineIBA
04/2015
1AntigensIBA
01/2015
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2014
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2014
1Paclitaxel (Taxol)FDA LinkGeneric
01/2014
1taxaneIBA
01/2014
1ThrombinFDA Link
11/2013
1gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA
08/2013
1OxygenIBA
07/2013
1CalciumIBA
09/2012
1CopperIBA
06/2011
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
06/2011
1Retinaldehyde (Retinal)IBA
06/2011
1Methotrexate (Mexate)FDA LinkGeneric
09/2010
1Insulin (Novolin)FDA Link
08/2010
1LeptinIBA
08/2010
1benfluorex (S 780)IBA
08/2010
1Molecular Probes (Molecular Probe)IBA
07/2010
1Gadolinium DTPA (Magnevist)FDA Link
05/2010
1tranilast (N 5')IBA
05/2010
1CytokinesIBA
11/2009
1harpin (messenger)IBA
11/2009
1Angiogenesis InhibitorsIBA
09/2009
1Proteoglycans (Proteoglycan)IBA
09/2009
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
09/2009
1ManganeseIBA
06/2009
1Glutathione (Reduced Glutathione)IBA
03/2009
1Ventricular MyosinsIBA
03/2009
1Acetylcysteine (Siran)FDA LinkGeneric
03/2009
1Actins (F Actin)IBA
03/2009
1Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA
03/2009

Therapy/Procedure

3Drug Therapy (Chemotherapy)
01/2014 - 01/2009
2Transplants (Transplant)
12/2012 - 11/2012
2Heterologous Transplantation (Xenotransplantation)
08/2010 - 03/2005
2Microbubbles
06/2006 - 02/2005
1Injections
10/2014
1Ligation
01/2014
1Angioplasty (Angioplasty, Transluminal)
01/2012
1Stents
01/2012
1Therapeutics
09/2009